Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to Daratumumab

Conditions:   Amyloid;   AL Amyloidosis;   Refractory AL Amyloidosis Interventions:   Drug: Daratumumab;   Drug: Pomalidomide;   Drug: Dexamethasone Sponsors:   Weill Medical College of Cornell University;   Janssen Scientific Affairs, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials